Baxter International Inc has initiated a voluntary recall to the hospital/user level of 3 lots of 0.9% sodium chloride and 1 lot of potassium chloride intravenous (IV) solutions because of the ...
Baxter International Inc has initiated a voluntary recall of 1 lot of 5% dextrose injection and 4 lots of 0.9% sodium chloride injection intravenous (IV) solutions because of the presence of ...
Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market DEERFIELD, Ill., May 15, 2015 - Baxter International Inc. (NYSE: BAX) ...
Long Grove Pharmaceuticals announced the strategic in-licensing of norepinephrine in 0.9% sodium chloride premix formulation from Nevakar Injectables. This manufactured, ready-to-use formulation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback